diabetes glp-1 agonist GLP1 Receptor Agonists—Effects beyond Obesity and GLP-1 Agonists - What is
Description
doi: 10.7326/M22-3078 [DOI] [PMC free article] [PubMed] [Google Scholar] 7
The aim of this review was to summarize the recent updates from both clinical trials and preclinical experiments on the impact of GLP-1 receptor agonists (GLP-1RAs) and DPP-4 inhibitors (DPP-4i) on cardiovascular outcomes
J.AraiY
The computational algorithm for ROR determination is detailed in Supplementary Table 1
doi: 10.1002/oby.23910
Current literature suggests that this potential in lowering intracranial pressure is associated with its correlation in reducing CSF secretion through a protein kinase signaling pathway [104]
